Diatranz Otsuka
2011
FOUNDED
M&A
STATUS
2ndary - Private
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Developer of cellular therapies designed to improve the lives of people living with serious disease. The company's cellular therapies uses incredible biological similarities between humans and other mammals to develop therapies by using animal cells and tissues, enabling pharmaceutical companies to develop a breakthrough therapeutic option for a debilitating disease.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Otsuka Pharmaceutical Factory
Primary Office
- PO Box 23 566
- Auckland, 2155
- New Zealand
+64 09-276 0000
Diatranz Otsuka Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Diatranz Otsuka‘s full profile, request access.
Request full access to PitchBookDiatranz Otsuka Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Diatranz Otsuka‘s full profile, request access.
Request full access to PitchBook